Venturelab's series about Switzerland’s most inspiring entrepreneurs and founders continues with Danuta Cichocka, the co-founder and CEO of Resistell AG.

For the first time Resistell with its Rapid AST made it to TOP100 this year! We are super proud and have big ambitions to climb up the list! Stay tuned!

Join us in Zurich at the Annual Meeting of Swiss Society for Microbiology and learn more about our rapid AST solution. We invite you to our booth number 24. See you soon!

In the immensity of the cosmos, could life develop on another planet than Earth? Nano-motion device invented be Sandor Kasas and Giovanni Dietler from EPFL Lausanne...

Thank you for giving us the opportunity to take part in the Pitch Night Boston 2019: The Future of HealthTech and to present our rapid AST.

Join Resistell at OBERON to see our Rapid AST solution at Pitch Night 2019, where 10 of Switzerland’s most promising young HealthTech startups will pitch their ideas alongside their counterparts from North America, including some of the Boston area’s favorite early Life Sciences startups.

We would like to thank the colleagues from the Uppsala Antibiotic Centre for the invitation to an excellent Symposium on Rapid ASTs. We are impressed by the quality of the event, participants and the discussions and honoured to be an invited speaker.

Learn more on rapid phenotypic antibiotic susceptibility test and Danuta's expectations on her roadshow in Boston.

Vote for Resistell at Top 100 Startups

a thrilling evening for innovators in Switzerland

Danuta selected as top four up-and-coming entrepreneurs who made the best pitch at the annual Startup Champions Seed Night. Watch us on CNN Money and see how we will take our startup to the next level.

We invite you to meet us in Amsterdam at ECCMID 2019 (13 - 16 April 2019) and learn more about our rapid AST approach, see the product and discuss the future cooperations. Meet us any time at the booth 1.107!

D.Day 2019 – Discover what your neighbours are working on!

“This process is one of the most rapid methods in this review and can be used to develop quantitative anti-biograms”, Puttaswamy et al., 2018, Archives of Clinical Microbiology, 9:3, 83 https://doi.org/10.4172/1989-8436.100083

Well done to all our colleagues from CHUV Hospital, recently listed in the top 10 best hospitals in the world. Resistell is proud to develop the rapid AST with the support of CHUV Hospital. Thank you and congratulations!